104 related articles for article (PubMed ID: 12413856)
1. Development of 3D-QSAR models for 5-lipoxygenase antagonists: chalcones.
Arockia Babu M; Shakya N; Prathipati P; Kaskhedikar SG; Saxena AK
Bioorg Med Chem; 2002 Dec; 10(12):4035-41. PubMed ID: 12413856
[TBL] [Abstract][Full Text] [Related]
2. 3-D QSAR studies of triazolinone based balanced AT1/AT2 receptor antagonists.
Pandya T; Pandey SK; Tiwari M; Chaturved SC; Saxena AK
Bioorg Med Chem; 2001 Feb; 9(2):291-300. PubMed ID: 11249122
[TBL] [Abstract][Full Text] [Related]
3. Comparative molecular field analysis and molecular docking studies on novel aryl chalcone derivatives against an important drug target cysteine protease in Plasmodium falciparum.
Thillainayagam M; Anbarasu A; Ramaiah S
J Theor Biol; 2016 Aug; 403():110-128. PubMed ID: 27185536
[TBL] [Abstract][Full Text] [Related]
4. 3D QSAR studies on antimalarial alkoxylated and hydroxylated chalcones by CoMFA and CoMSIA.
Xue CX; Cui SY; Liu MC; Hu ZD; Fan BT
Eur J Med Chem; 2004 Sep; 39(9):745-53. PubMed ID: 15337287
[TBL] [Abstract][Full Text] [Related]
5. Discovery of structurally diverse HIV-1 integrase inhibitors based on a chalcone pharmacophore.
Deng J; Sanchez T; Al-Mawsawi LQ; Dayam R; Yunes RA; Garofalo A; Bolger MB; Neamati N
Bioorg Med Chem; 2007 Jul; 15(14):4985-5002. PubMed ID: 17502148
[TBL] [Abstract][Full Text] [Related]
6. A proposed common spatial pharmacophore and the corresponding active conformations of some peptide leukotriene receptor antagonists.
Hariprasad V; Kulkarni VM
J Comput Aided Mol Des; 1996 Aug; 10(4):284-92. PubMed ID: 8877700
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: molecular docking and 3D-QSAR analyses.
Liu G; Zhang Z; Luo X; Shen J; Liu H; Shen X; Chen K; Jiang H
Bioorg Med Chem; 2004 Aug; 12(15):4147-57. PubMed ID: 15246091
[TBL] [Abstract][Full Text] [Related]
8. Structure-based approach to pharmacophore identification, in silico screening, and three-dimensional quantitative structure-activity relationship studies for inhibitors of Trypanosoma cruzi dihydrofolate reductase function.
Schormann N; Senkovich O; Walker K; Wright DL; Anderson AC; Rosowsky A; Ananthan S; Shinkre B; Velu S; Chattopadhyay D
Proteins; 2008 Dec; 73(4):889-901. PubMed ID: 18536013
[TBL] [Abstract][Full Text] [Related]
9. Antileishmanial chalcones: statistical design, synthesis, and three-dimensional quantitative structure-activity relationship analysis.
Nielsen SF; Christensen SB; Cruciani G; Kharazmi A; Liljefors T
J Med Chem; 1998 Nov; 41(24):4819-32. PubMed ID: 9822551
[TBL] [Abstract][Full Text] [Related]
10. Phenylpropiophenone derivatives as potential anticancer agents: synthesis, biological evaluation and quantitative structure-activity relationship study.
Ivković BM; Nikolic K; Ilić BB; Žižak ŽS; Novaković RB; Čudina OA; Vladimirov SM
Eur J Med Chem; 2013 May; 63():239-55. PubMed ID: 23501110
[TBL] [Abstract][Full Text] [Related]
11. Essential structural profile of a dual functional inhibitor against cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX): molecular docking and 3D-QSAR analyses on DHDMBF analogues.
Zheng M; Zhang Z; Zhu W; Liu H; Luo X; Chen K; Jiang H
Bioorg Med Chem; 2006 May; 14(10):3428-37. PubMed ID: 16458008
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, biological evaluation and 3D-QSAR studies of new chalcone derivatives as inhibitors of human P-glycoprotein.
Parveen Z; Brunhofer G; Jabeen I; Erker T; Chiba P; Ecker GF
Bioorg Med Chem; 2014 Apr; 22(7):2311-9. PubMed ID: 24613626
[TBL] [Abstract][Full Text] [Related]
13. A geranylated chalcone with 5alpha-reductase inhibitory properties from Artocarpus incisus.
Shimiz K; Kondo R; Sakai K; Buabarn S; Dilokkunanant U
Phytochemistry; 2000 Aug; 54(8):737-9. PubMed ID: 11014257
[TBL] [Abstract][Full Text] [Related]
14. Structural requirements for inhibition of the neuronal nitric oxide synthase (NOS-I): 3D-QSAR analysis of 4-oxo- and 4-amino-pteridine-based inhibitors.
Matter H; Kotsonis P; Klingler O; Strobel H; Fröhlich LG; Frey A; Pfleiderer W; Schmidt HH
J Med Chem; 2002 Jul; 45(14):2923-41. PubMed ID: 12086480
[TBL] [Abstract][Full Text] [Related]
15. 4D-QSAR analysis of a series of antifungal p450 inhibitors and 3D-pharmacophore comparisons as a function of alignment.
Liu J; Pan D; Tseng Y; Hopfinger AJ
J Chem Inf Comput Sci; 2003; 43(6):2170-9. PubMed ID: 14632469
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anti-inflammatory activity of chalcone derivatives.
Herencia F; Ferrándiz ML; Ubeda A; Domínguez JN; Charris JE; Lobo GM; Alcaraz MJ
Bioorg Med Chem Lett; 1998 May; 8(10):1169-74. PubMed ID: 9871729
[TBL] [Abstract][Full Text] [Related]
17. 3D-QSAR with the aid of pharmacophore search and docking-based alignments for farnesyltransferase inhibitors.
Vaidya M; Weigt M; Wiese M
Eur J Med Chem; 2009 Oct; 44(10):4070-82. PubMed ID: 19515462
[TBL] [Abstract][Full Text] [Related]
18. 3,4-Dihydroxychalcones as potent 5-lipoxygenase and cyclooxygenase inhibitors.
Sogawa S; Nihro Y; Ueda H; Izumi A; Miki T; Matsumoto H; Satoh T
J Med Chem; 1993 Nov; 36(24):3904-9. PubMed ID: 8254620
[TBL] [Abstract][Full Text] [Related]
19. Investigations of Structural Requirements for BRD4 Inhibitors through Ligand- and Structure-Based 3D QSAR Approaches.
Tahir A; Alharthy RD; Naseem S; Mahmood N; Ahmed M; Shahzad K; Akhtar MN; Hameed A; Sadiq I; Nawaz H; Muddassar M
Molecules; 2018 Jun; 23(7):. PubMed ID: 29941841
[TBL] [Abstract][Full Text] [Related]
20. Active site characterization and structure based 3D-QSAR studies on non-redox type 5-lipoxygenase inhibitors.
Ul-Haq Z; Khan N; Zafar SK; Moin ST
Eur J Pharm Sci; 2016 Jun; 88():26-36. PubMed ID: 27044904
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]